Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Likely No. 1 pick Zion Williamson is expected to sign a lucrative sneaker endorsement deal prior to this year's May 14 draft lottery, with sneaker companies confident he'll be a marketing superstar no matter where he lands.

Why it matters: Many in the sneaker industry believe Williamson's deal will make him one of the three highest-paid rookie sneaker endorsers ever, rivaling LeBron James and Kevin Durant.

  • Draft odds: As of this morning, New York, Phoenix and Cleveland all have a 14% chance of landing the top pick, with Chicago (12.5%) and Atlanta (10.5%) not too far behind.
"In my lifetime, I think it's going to be the biggest bidding war ever done. ... He is going to have an opportunity to be the face of every company and every major corporation. He is the most marketable person I've seen, for a lot of different reasons."
— — Famed sneaker exec Sonny Vaccaro (via ESPN)

Details: Zion will almost certainly get his own signature shoe, which is something only nine rookies in league history have ever gotten.

  • They are: Lonzo Ball (Big Baller Brand), LeBron James (Nike), Stephon Marbury (AND1), Allen Iverson (Reebok), Jerry Stackhouse (Fila), Grant Hill (Fila), Shaquille O'Neal (Reebok), Michael Jordan (Nike), Hakeem Olajuwon (Etonic).

The brands: Nike (which he has some explosive history with, of course) and Adidas (which he grew up wearing) are the two biggest players, but let's be honest — every brand is going to at least take a run at this.

  • Under Armour just signed Joel Embiid to a massive contract and has invested a ton of money into Steph Curry's overall business, so they could be strapped for cash.
  • Puma and New Balance both re-entered the basketball sneaker market last year. Might they swing for the fences in hopes that Zion could do for them what Jordan did for Nike? Do they have deep enough pockets to make it happen?
  • Chinese brand Anta, which has a deals with Klay Thompson and Gordon Hayward, can't be counted out.

The good news for Zion: The NBA is expected to allow players to enter the league directly out of high school as soon as the 2022 draft, meaning Williamson could be one of the last "lightning-in-a-bottle NCAA superstars entering the NBA with a global social media profile," writes ESPN's Nick DePaula.

  • That will work in his favor, as will the fact that he's not only a superstar on the court but also a well-spoken, extremely likable human off of it.
  • Plus, the NBA is exploding in global popularity and has a unique connection to culture that other leagues can't quite match. That makes its athletes that much more attractive — and likely worth any shoe sales-related risk.

The bad news: Speaking of shoe sales-related risk ... one could argue that Zion is entering the league at precisely the wrong time, with basketball shoes accounting for just 4% of the shoe market in 2018, down from a high of 13% just a few years earlier.

  • "The basketball sneaker business is just terrible right now," Matt Powell, a sports industry analyst at NPD Group, told me.
  • "[Zion] isn't going to generate a lot of shoe sales, so how much do you pay a guy who is essentially going to be an ambassador for your brand? I don't want to make it sound like there's no value there, but I just can't justify the cost."

Related: Why LeBron turned down $115 million from Reebok and signed with Nike for $87 million

Go deeper

Starbucks drops worker vaccine or test requirement after SCOTUS ruling

Photo: Jakub Porzycki/NurPhoto via Getty Images

Starbucks has dropped plans to require that U.S. workers get the COVID vaccine or submit to weekly testing, the company announced Tuesday in a memo to employees.

Why it matters: The company's decision comes in response to the Supreme Court's ruling last week to block the Biden administration's COVID-19 vaccine-or-test requirement for large employers.

3 hours ago - World

Netanyahu plea talks enter crunch time

Netanyahu (right) meets with his lawyer ahead of a court hearing last February. Photo: Reuven Casto/Pool/AFP via Getty

Benjamin Netanyahu, Israel's opposition leader and former prime minister, is negotiating a possible plea deal over the corruption charges against him, but Attorney General Avichai Mandelblit appears to be toughening his terms.

Why it matters: Mandelblit leaves office on Jan. 31. Negotiations could continue beyond that point, but the next attorney general may be less interested in quickly reaching a deal.

3 hours ago - Health

Omicron hits American hospitals disproportionately hard

Expand chart
Data: Our World in Data; Chart: Will Chase/Axios

America is seeing more COVID hospitalizations than other wealthy countries during the Omicron surge, according to Our World in Data.

Why it matters: Vaccines keep the vast majority of COVID cases out of the hospital, but vaccination rates are also lower in the U.S. than these other countries.